title: Proteolysis of complement factors iC3b and C5 by the serine protease prostate-specific antigen in prostatic fluid and seminal plasma.
abstract: Prostate-specific Ag (PSA) is a serine protease that is expressed exclusively by normal and malignant prostate epithelial cells. The continued high-level expression of PSA by the majority of men with both high- and low-grade prostate cancer throughout the course of disease progression, even in the androgen-ablated state, suggests that PSA has a role in the pathogenesis of disease. Current experimental and clinical evidence suggests that chronic inflammation, regardless of the cause, may predispose men to prostate cancer. The responsibility of the immune system in immune surveillance and eventually tumor progression is well appreciated but not completely understood. In this study, we used a mass spectrometry-based evaluation of prostatic fluid obtained from diseased prostates after removal by radical prostatectomy to identify potential immunoregulatory proteins. This analysis revealed the presence of Igs and the complement system proteins C3, factor B, and clusterin. Verification of these findings by Western blot confirmed the high-level expression of C3 in the prostatic fluid and the presence of a previously uncharacterized C-terminal C3 cleavage product. Biochemical analysis of this C3 cleavage fragment revealed a putative PSA cleavage site after tyrosine-1348. Purified PSA was able to cleave iC3b and the related complement protein C5. These results suggest a previously uncharacterized function of PSA as an immunoregulatory protease that could help to create an environment hospitable to malignancy through proteolysis of the complement system.
authors: Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
authors: Michael L
authors: ML
authors: Manning
authors: Simon A
authors: SA
authors: Williams
authors: Christine A
authors: CA
authors: Jelinek
authors: Maya B
authors: MB
authors: Kostova
authors: Samuel R
authors: SR
authors: Denmeade
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor / Q000276:immunology*; D001826:Body Fluids / Q000201:enzymology / Q000276:immunology; D002460:Cell Line; D003179:Complement C3b / Q000378:metabolism*; D003182:Complement C5 / Q000378:metabolism*; D006801:Humans; D008297:Male; D011467:Prostate / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000276:immunology / Q000502:physiology*; D011471:Prostatic Neoplasms / Q000201:enzymology / Q000276:immunology; D059748:Proteolysis; D012661:Semen / Q000201:enzymology / Q000276:immunology*; D057057:Serine Proteases / Q000502:physiology*; D012756:Sheep
chemical_list: D014408:Biomarkers, Tumor; D003182:Complement C5; D003179:Complement C3b; D057057:Serine Proteases; D017430:Prostate-Specific Antigen
references: Nat Rev Cancer. 2007 Apr;7(4):256-69
references: 17384581
references: Nature. 2006 Nov 9;444(7116):213-6
references: 17051160
references: Immunol Rev. 2001 Apr;180:35-48
references: 11414361
references: Am J Reprod Immunol. 1984 Jul-Aug;6(1):28-32
references: 6383086
references: Prostate. 2001 Jun 15;48(1):1-6
references: 11391681
references: Nature. 2005 Sep 22;437(7058):505-11
references: 16177781
references: Proc Natl Acad Sci U S A. 1986 May;83(10):3166-70
references: 2422647
references: Genome Biol. 2006;7(5):R40
references: 16709260
references: J Lab Clin Med. 1980 Oct;96(4):582-91
references: 6775032
references: Prostate. 2011 Nov;71(15):1595-607
references: 21394741
references: J Immunol Methods. 1999 Jan 1;222(1-2):73-82
references: 10022374
references: Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13236-40
references: 21788512
references: Curr Protoc Cell Biol. 2004 May;Chapter 15:Unit 15.7
references: 18228442
references: J Immunol. 2001 Feb 15;166(4):2635-42
references: 11160326
references: Prostate. 2008 Jun 1;68(8):872-82
references: 18361406
references: Mol Biol Evol. 1994 May;11(3):417-25
references: 8015436
references: Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19737-42
references: 17172439
references: Nature. 2006 Nov 9;444(7116):217-20
references: 17051150
references: Prostate. 2009 Feb 1;69(2):208-13
references: 18942121
references: Chem Biol. 2008 Jul 21;15(7):665-74
references: 18635003
references: J Clin Invest. 1985 Nov;76(5):1899-903
references: 3902893
references: N Engl J Med. 2001 Apr 5;344(14):1058-66
references: 11287977
references: J Clin Endocrinol Metab. 1992 Oct;75(4):1046-53
references: 1383255
references: Prostate. 2007 Feb 15;67(3):312-29
references: 17143882
references: J Cell Physiol. 2005 Feb;202(2):361-70
references: 15389580
references: J Biol Chem. 1989 Jan 25;264(3):1894-900
references: 2912989
references: J Clin Invest. 1981 May;67(5):1523-31
references: 6785314
references: J Urol. 1996 Aug;156(2 Pt 1):526-31
references: 8683730
references: Cell Microbiol. 2007 Sep;9(9):2095-102
references: 17590164
references: Clin Exp Immunol. 1987 Jun;68(3):703-11
references: 3498585